Further defining the roles and impact of genetic counselors in the biotechnology and pharmaceutical industry

Author:

Maxwell Emily12ORCID,Moore Rebekah3,Niendorf Kristin4,Field Tessa5

Affiliation:

1. Genetic Counseling Program MGH Institute of Health Professions Boston Massachusetts USA

2. Fred Hutchinson Cancer Institute Seattle Washington USA

3. AstraZeneca Pharmaceuticals One MedImmune Way Gaithersburg Maryland USA

4. Genetic Counseling Program Indiana State University Terre Haute Indiana USA

5. Spark Therapeutics Philadelphia Pennsylvania USA

Abstract

AbstractAs personalized medicine has gained traction, drug development models in the biotechnology and pharmaceutical industry (BPI) have increasingly sought to address medical conditions with a genetic component, creating an opportunity for genetic counselors (GCs) to fill new roles and utilize their unique training to contribute to drug development. Despite the potential for GCs in BPI, literature around the role of GCs in this industry has been limited. Our mixed methods study aimed to assess how the roles of GCs in BPI have evolved since 2016, investigate the value of and opportunity for GCs in this industry, and further characterize their motivation and job satisfaction. Participants were recruited via social media advertising, snowball sampling, and email listservs from the National Society of Genetic Counseling (NSGC), the Canadian Association of Genetic Counselors (CAGC), and the American Board of Genetic Counseling (ABGC). Survey (n = 20) and interview (n = 6) data indicates many aspects of GC roles in BPI are consistent with the 2016 study. However, there is evidence of roles becoming more varied and with increasing recognition of the value of GCs, opportunities for involvement in BPI are growing. Furthermore, combined study data found that GCs are motivated by the flexibility of BPI roles as well as the opportunity to contribute to rare disease treatment development and that they are overall satisfied with most aspects of their jobs. Interview data also found that genetic counseling training has the potential to improve clinical trial design and outcomes by making drug development more patient‐centric. Finally, combined study data found that while GCs continue to utilize Accreditation Council of Genetic Counseling (ACGC) practice‐based competencies (PBCs), business‐related training may benefit GCs seeking to enter BPI. Together, these findings are critical for informing genetic counseling training programs, employers within BPI, and GCs interested in entering these positions.

Publisher

Wiley

Reference19 articles.

1. Accreditation Council for Genetic Counseling. (2021).Practice‐based competencies for genetic counselors.https://www.gceducation.org/wp‐content/uploads/2022/10/ACGC‐Core‐Competencies‐Brochure_15_Web_REV‐6‐2019.pdf

2. Scaling Genetic Counseling in the Genomics Era

3. Genetic counselors on the frontline of precision health

4. Using thematic analysis in psychology

5. Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3